top of page
Search
Understanding the mechanisms of idiopathic pulmonary fibrosis in order to develop new treatments
IPF is a progressive and devastating lung disorder characterised by irreversible scarring (fibrosis) of the lung. IPF affects over 8,000 peo
Glenn Hearson
Nov 7, 2016
Amplification of TGFβ Induced ITGB6 Gene Transcription May Promote Pulmonary Fibrosis
Idiopathic pulmonary fibrosis (IPF) is a devastating, progressive disease with poor survival rates and limited treatment options. Upregulati
Glenn Hearson
Sep 4, 2016
Reduced Ets Domain-containing Protein Elk1 Promotes Pulmonary Fibrosis via Increased Integrin αvβ6
Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic lung disease with high mortality. Active TGFβ1 is considered central to the pa
Glenn Hearson
May 28, 2016
Prospective study Of Fibrosis In the Lung Endpoints (PROFILE)
Completed IPF Study The overall aim of this study is to develop a test that predicts the prognosis of IPF (Idiopathic Pulmonary Fibrosis)...
Glenn Hearson
Jan 27, 2016
RAINIER IPF Study
Completed IPF Study Multi-Center Study Commercial Clinical Trial to Assess the Efficacy and Safety of GS-6624 in Subjects with Idiopathic...
Glenn Hearson
Jan 20, 2016
Novel approaches to pulmonary fibrosis
Review of recent discoveries around the underlying pathophysiology of IPF which have stimulated the development of novel therapies and new m
Glenn Hearson
Jan 28, 2015
bottom of page